Uveitis Update 2013
This course will review the latest treatment modalities in uveitis including the intravitreal delivery systems for long acting and short acting steroids and the various anti-tumor necrosis factor alpha agents. We will compare these new treatments to the currently accepted systemic immunosuppression regimens with steroids and nonsteroidal immunosuppressive therapy.
Updates on infectious uveitis syndromes will be presented. Case presentations with emphasis on audience interaction will provide insight on how to conduct a uveitis work up and how to treat various syndromes.
At the conclusion of this course, participants will be able to:
1. Describe the use of nonspecific drugs including immunosuppressive therapy.
2. Describe current clinical trials in ocular inflammatory diseases.
3. Identify newer therapies for non-infectious posterior uveitis syndromes.
4. Discuss evaluation and treatment of patients with uveitis.
General Ophthalmologists, Uveitis and Vitreoretinal Specialists, Optometrists, Internists, Rheumatologists, Pulmonary and Paramedical Personnel.
Intermediate Uveitis & Pars Planitis
Toxoplasmosis: Subretinal Abscess. A diagnostic dilemma.